TCL Archive Cooperative Group Competing Renewals May Be Funded Only at 70-80% Of Amounts Recommended By CCIRC January 2, 1981
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012